Patent application – provisional & non-provisional MCQs With Answer

Introduction: This quiz collection on “Patent application – provisional & non‑provisional MCQs With Answer” is tailored for M.Pharm students studying Pharmaceutical Validation. It highlights key legal and procedural aspects of patent filings relevant to drug development, including distinguishing provisional and complete (non‑provisional) applications, timelines for priority and conversion, publication and examination rules, and patentability criteria such as novelty, inventive step and sufficiency of disclosure. Understanding these concepts is essential for validating documentation, protecting pharmaceutical innovations, and planning regulatory strategy. The questions focus on practical scenarios, statutory timelines and best practices that pharmacists and researchers must know when preparing and managing patent applications.

Q1. What best describes a provisional patent application?

  • An initial filing that establishes an early priority date and is usually followed by a complete application within 12 months
  • A final examined application that directly leads to patent grant without further filings
  • A regional patent application filed under the PCT national phase
  • An application that automatically extends patent term by 12 months

Correct Answer: An initial filing that establishes an early priority date and is usually followed by a complete application within 12 months

Q2. Under the Paris Convention, within how many months must a complete (non‑provisional) application be filed to claim priority from a provisional filing?

  • 6 months
  • 12 months
  • 18 months
  • 36 months

Correct Answer: 12 months

Q3. What is the typical maximum term of patent protection from the effective filing date in most jurisdictions?

  • 14 years
  • 20 years
  • 25 years
  • 10 years

Correct Answer: 20 years

Q4. When is a patent application normally published if no early publication is requested?

  • Immediately upon filing
  • 12 months from filing
  • 18 months from the earliest priority or filing date
  • 36 months from filing

Correct Answer: 18 months from the earliest priority or filing date

Q5. In India, within how many months must an applicant file a request for examination for a patent application?

  • 12 months
  • 24 months
  • 48 months
  • 60 months

Correct Answer: 48 months

Q6. Under the PCT system, by about how many months after the priority date must an applicant normally enter national phase in most countries?

  • 12 months
  • 18 months
  • 30 months
  • 48 months

Correct Answer: 30 months

Q7. Which of the following is generally NOT required when filing a provisional patent application (e.g., in the US)?

  • A sufficient written description or specification
  • Formal patent claims
  • A filing date and title
  • Filing fee

Correct Answer: Formal patent claims

Q8. What does the term “priority date” refer to in patent practice?

  • The date the patent is granted
  • The date of the first filing in a convention country from which priority is claimed
  • The date of international publication
  • The date of the first commercial sale

Correct Answer: The date of the first filing in a convention country from which priority is claimed

Q9. Which characteristic most accurately describes a non‑provisional (complete) patent application?

  • It is a temporary document that never contains claims
  • It contains claims, a detailed specification, and is examined for grant
  • It is only for international filings and cannot be examined
  • It automatically converts into a granted patent after 6 months

Correct Answer: It contains claims, a detailed specification, and is examined for grant

Q10. Can a provisional application by itself lead to a granted patent?

  • Yes, provisional applications are sufficient for grant
  • No, a provisional alone cannot lead to grant without filing a complete/non‑provisional application
  • Yes, but only after 18 months
  • Only if filed under PCT

Correct Answer: No, a provisional alone cannot lead to grant without filing a complete/non‑provisional application

Q11. For pharmaceutical inventions, what is the best practice when filing a provisional specification?

  • Include only a title and leave details for the complete filing
  • Provide an enabling disclosure sufficient to support future claims
  • Submit only claims without description
  • File only drawings and no experimental data

Correct Answer: Provide an enabling disclosure sufficient to support future claims

Q12. What is the consequence of failing to file the complete (non‑provisional) application within 12 months of a provisional filing?

  • The provisional is automatically extended for another 12 months
  • The priority benefit is lost and the provisional lapses
  • The patent is granted based on the provisional
  • No effect; you can file at any time later with same priority

Correct Answer: The priority benefit is lost and the provisional lapses

Q13. Which of the following is NOT a statutory patentability requirement?

  • Novelty
  • Inventive step (non‑obviousness)
  • Industrial applicability (usefulness)
  • Market potential

Correct Answer: Market potential

Q14. When can a pre‑grant opposition typically be filed against a patent application in India?

  • Only after the patent is granted
  • Anytime after publication of the application and before grant
  • Before filing the application
  • Only within 30 days of filing

Correct Answer: Anytime after publication of the application and before grant

Q15. What does the “unity of invention” requirement ensure in a patent application?

  • That claims cover all possible uses of a molecule
  • That all claims relate to a single general inventive concept
  • That the applicant lists multiple inventors
  • That the application contains only one claim

Correct Answer: That all claims relate to a single general inventive concept

Q16. What is meant by “sufficiency of disclosure” in patent law?

  • The application must include a market analysis
  • The disclosure must enable a person skilled in the art to carry out the invention without undue experimentation
  • The applicant must disclose competitor names
  • The application should provide clinical trial data for all claims

Correct Answer: The disclosure must enable a person skilled in the art to carry out the invention without undue experimentation

Q17. To retain the benefit of a provisional filing date when filing the complete application, the applicant must:

  • Pay a supplemental provisional fee within 6 months
  • Claim priority to the provisional in the complete application
  • File an entirely new invention disclosure
  • Request expedited examination immediately

Correct Answer: Claim priority to the provisional in the complete application

Q18. Does filing a provisional application start the 20‑year patent term in most jurisdictions?

  • Yes, the 20‑year term begins from the provisional filing date
  • No, the patent term is generally calculated from the filing date of the non‑provisional/complete application used for grant
  • Yes, but only for pharmaceuticals
  • Only if the provisional contains claims

Correct Answer: No, the patent term is generally calculated from the filing date of the non‑provisional/complete application used for grant

Q19. Why might an applicant request early publication of a patent application?

  • To immediately shorten the patent term
  • To make the invention public sooner and start the period for pre‑grant opposition or potential licensing negotiations
  • To avoid examination entirely
  • To delay national phase entry under PCT

Correct Answer: To make the invention public sooner and start the period for pre‑grant opposition or potential licensing negotiations

Q20. In a non‑provisional (complete) patent application, which component primarily defines the legal scope of monopoly being sought?

  • The abstract
  • The claims
  • The drawings
  • The cover letter

Correct Answer: The claims

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators